NuVasive Inc (NUVA)

Medical technology companies are hot, says Rich Newitter, managing director at Leerink.

Medical technology companies are hot and not even climbing price-to-earnings multiples will slow down the likes of Hologic, Zimmer Biomet, Zeltiq and NuVasive.

These four small-cap stocks would be a healthy addition to your portfolio, says David Swank, portfolio manager for the Hood River Small-Cap Growth Fund.

Zimmer's return to growth is fueling acquisition thoughts by analysts. There are a number of possibilities.

Zimmer Biomet is on track to return to growth, which could signal more mergers and acquisitions within the industry.

TheStreet Quant Ratings provides fair and objective information to help you make educated investing decisions. We rate over 4,300 stocks daily and provide 5-page PDF reports for each stock. These ratings can change daily and today's changes are reflected in the email below. If you are looking to check-up on the stocks you currently own or are looking for new ideas, you can find our full database of password-protected ratings reports in our proprietary ratings screener: http://www.thestreet.com/k/qr/flat/stock-screener.html Upgrades: AWRE, CRD.B, NUVA, SIRI, SNBC, TI, TI.A, TNC Downgrades: DD, HOT, TRNS, TROW, ZIXI Initiations: TRU, XTLY, YECO Read on to get TheStreet Quant Ratings' detailed report:

Trade-Ideas LLC identified NuVasive (NUVA) as a new lifetime high candidate

Here are Wednesday's top research calls, including an upgrade for Pandora, and downgrades for Darden Restaurants, MetLife and Yelp.

This group of nibblers triggered a modest reversal leading into the Fed’s late-afternoon minutes.

These medical device makers could be acquisition targets (and one buyer) following Zimmer Biomet's takeout of LDR Holding. Their charts are also buys, says technical chartist Bruce Kamich.

The $1 billion transaction could inspire other medical device companies and private equity firms to bend over backwards for spinal device assets.

The hefty premium Zimmer Biomet is paying in the $1 billion deal for the spine company suggests the target's management followed a competitive process.

The target's shares soar on heels of latest back treatment acquisition.

Zimmer Biomet's move to acquire LDR Holding is a smart one and it also bodes well for another medical device company NuVasive, said TheStreet's Jim Cramer.

Trade-Ideas LLC identified NuVasive (NUVA) as a new lifetime high candidate

Jim Cramer talks about how the jobs numbers baffle him and says not to give up on this market.

Cramer gives the edge to TJX over Ross Stores and is a fan of NuVasive.

When investors get complacent, they miss out on great opportunities to buy, Cramer says.

NuVasive (NUVA) stock was raised to 'equal weight' from 'overweight' at Barclays.

Here are Friday's top research calls, including downgrades for Deckers, Palo Alto Networks, Signet Jewelers and Workday.

TheStreet Quant Ratings provides fair and objective information to help you make educated investing decisions. We rate over 4,300 stocks daily and provide 5-page PDF reports for each stock. These ratings can change daily and today's changes are reflected in the email below. If you are looking to check-up on the stocks you currently own or are looking for new ideas, you can find our full database of password-protected ratings reports in our proprietary ratings screener: http://www.thestreet.com/k/qr/flat/stock-screener.html Upgrades: ARTX, BSX, CBL, ESRT, GV, KRA, LDOS, NNBR, UTX Downgrades: BEN, CHU, DSPG, DX, NUVA, PNRG, QGEN, WBC, WRE Initiations: None Read on to get TheStreet Quant Ratings' detailed report:

Trade-Ideas LLC identified NuVasive (NUVA) as a strong and under the radar candidate

The most recent short interest data has been released by the NASDAQ for the 03/31/2016 settlement date, which shows a 391,021 share increase in total short interest for Nuvasive Inc , to 3,165,855, an increase of 14.09% since 03/15/2016. Total short interest is just one way to look at short data; another metric that we here at Dividend Channel find particularly useful is the "days to cover" metric because it considers both the total shares short and the average daily volume of shares traded.

Trade-Ideas LLC identified NuVasive (NUVA) as a pre-market mover with heavy volume candidate

Trade-Ideas LLC identified NuVasive (NUVA) as a "dead cat bounce" (down big yesterday but up big today) candidate

Trade-Ideas LLC identified NuVasive (NUVA) as a strong and under the radar candidate

Worldwide markets are selling off on news from North Korea that it has successfully tested a hydrogen nuclear bomb.

Trade-Ideas LLC identified NuVasive (NUVA) as a strong and under the radar candidate